澳優(01717.HK)料首季多賺逾72% 股價午後升幅擴至19%創近九個月高
澳優(01717.HK)午後發盈喜,料首季純利多賺逾72%,該股午後升幅擴至19%,報15.18元,創近九個月高,成交急增至1,044萬股,涉資1.45億元。
澳優發盈喜指,受惠自家品牌配方羊奶粉及牛奶粉產品銷售額增長,預計今年首季收入按年按年增約26%-27%,至19.1-19.35億元人民幣,純利按年增約72%-79%至2.61-2.71億元。若撇除衍生金融工具之公允價值變動虧損,料首季經調整純利增長49%-54%,至2.9-3億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.